Alyeska Investment Group, L.P. Spruce Biosciences, Inc. Transaction History

Alyeska Investment Group, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.04 - $2.93 $624,000 - $1.76 Million	-600,000 Reduced 60.0%	400,000 $1.17 Million
Q1 2023 May 15, 2023	BUY	$1.15 - $3.17 $1.15 Million - $3.17 Million	1,000,000 New	1,000,000 $2.21 Million
Q2 2021 Aug 16, 2021	BUY	$10.12 - $17.46 $196,459 - $338,950	19,413 New	19,413 $218,000

15.4M

16.7K

1.1K

Ticker SPRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,560,200
Market Cap $9.42M
Description
Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.